A fundamental requisite for clinical efficacy of anti-viral and anti-tumor vaccines is the induction/expansion of Ag-specific CD4+ T cells; therefore, pre- and post- vaccination immune monitoring should evaluate and compare the presence, frequency, phenotype and function of Ag-specific CD4+ T cells. The gene discussed is CD4; the disease is neoplasm.